
Sign up to save your podcasts
Or


The National MS Society's National Medical Advisory Committee has issued its recommendations for MS disease-modifying therapies and the coronavirus (COVID-19), and we're sharing them in this episode.
You'll also hear about a new disease-modifying therapy that's about to receive FDA approval. We'll tell you about a clinical trial for a potential disease-modifying therapy for progressive MS that fell short of achieving its goals. And you'll hear about study results that indicate there are still a lot of people living with MS who aren't acting in their own best interest.
My guest this week is Dawnia Baynes. Besides being an MS Activist, Dawnia facilitates a very special MS support group, and last month, the Southern-California Nevada Chapter of the National MS Society named Dawnia their Inspirational Person of the Year.
We have a lot to talk about! Are you ready for RealTalk MS??! ___________ Make sure you're getting your COVID-19 info from credible sources :39The Coronavirus (COVID-19) and MS Disease-Modifying Therapies 2:41
Ozanimod scheduled for FDA Approval this Month 2:09
High-Dose Biotin For Progressive MS Fails to Improve Disability 7:41
Disease-Modifying Therapy Non-Compliance Among People Living with MS 9:07
My Interview with Dawnia Baynes 12:05
Share this Episode 24:26
Reminder...Please Donate to Walk-MS 24:46
___________
SHARE THIS EPISODE OF REALTALK MS
Just copy this link & paste it into your text or email: https://realtalkms.com/133
___________
ADD YOUR VOICE TO THE CONVERSATION
I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes.
Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!
Email: [email protected]Phone: (310) 526-2283
___________
LINKS
If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com
What You Need to Know About Coronavirus (COVID-19)
MS Disease-Modifying Treatment Guidelines for Coronavirus (COVID-19)
Non-Compliance With Disease-Modifying Therapies in Patients With Multiple Sclerosis: A Qualitative Analysis
Support Group for Teens Living with MS
Jon's WALK-MS Fundraising Page
Download the RealTalk MS App for iOS
Download the RealTalk MS App for Android
Give RealTalk MS a Rating & Review
___________
Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.
RealTalk MS Episode 133 Hosted By: Jon Strum Guests: Dawnia Baynes
Tags: MS, MultipleSclerosis, MSResearch, MSActivist, MSSociety, Coronavirus, COVID-19, RealTalkMS
Privacy Policy
By Jon Strum4.7
144144 ratings
The National MS Society's National Medical Advisory Committee has issued its recommendations for MS disease-modifying therapies and the coronavirus (COVID-19), and we're sharing them in this episode.
You'll also hear about a new disease-modifying therapy that's about to receive FDA approval. We'll tell you about a clinical trial for a potential disease-modifying therapy for progressive MS that fell short of achieving its goals. And you'll hear about study results that indicate there are still a lot of people living with MS who aren't acting in their own best interest.
My guest this week is Dawnia Baynes. Besides being an MS Activist, Dawnia facilitates a very special MS support group, and last month, the Southern-California Nevada Chapter of the National MS Society named Dawnia their Inspirational Person of the Year.
We have a lot to talk about! Are you ready for RealTalk MS??! ___________ Make sure you're getting your COVID-19 info from credible sources :39The Coronavirus (COVID-19) and MS Disease-Modifying Therapies 2:41
Ozanimod scheduled for FDA Approval this Month 2:09
High-Dose Biotin For Progressive MS Fails to Improve Disability 7:41
Disease-Modifying Therapy Non-Compliance Among People Living with MS 9:07
My Interview with Dawnia Baynes 12:05
Share this Episode 24:26
Reminder...Please Donate to Walk-MS 24:46
___________
SHARE THIS EPISODE OF REALTALK MS
Just copy this link & paste it into your text or email: https://realtalkms.com/133
___________
ADD YOUR VOICE TO THE CONVERSATION
I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes.
Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!
Email: [email protected]Phone: (310) 526-2283
___________
LINKS
If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com
What You Need to Know About Coronavirus (COVID-19)
MS Disease-Modifying Treatment Guidelines for Coronavirus (COVID-19)
Non-Compliance With Disease-Modifying Therapies in Patients With Multiple Sclerosis: A Qualitative Analysis
Support Group for Teens Living with MS
Jon's WALK-MS Fundraising Page
Download the RealTalk MS App for iOS
Download the RealTalk MS App for Android
Give RealTalk MS a Rating & Review
___________
Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.
RealTalk MS Episode 133 Hosted By: Jon Strum Guests: Dawnia Baynes
Tags: MS, MultipleSclerosis, MSResearch, MSActivist, MSSociety, Coronavirus, COVID-19, RealTalkMS
Privacy Policy

6,685 Listeners

5,108 Listeners

15 Listeners

6,436 Listeners

9,221 Listeners

51 Listeners

32 Listeners

124 Listeners

1,451 Listeners

635 Listeners

114 Listeners

11,416 Listeners

1,154 Listeners

3,601 Listeners

166 Listeners